683 Capital Management, LLC Amylyx Pharmaceuticals, Inc. Transaction History
683 Capital Management, LLC
- $1.28 Billion
- Q2 2025
A detailed history of 683 Capital Management, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 2,160,000 shares of AMLX stock, worth $17.7 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
2,160,000
Previous 2,411,400
10.43%
Holding current value
$17.7 Million
Previous $8.54 Million
62.2%
% of portfolio
1.08%
Previous 0.69%
Shares
6 transactions
Others Institutions Holding AMLX
# of Institutions
142Shares Held
75.8MCall Options Held
212KPut Options Held
40.6K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.8MShares$72.2 Million0.1% of portfolio
-
Perceptive Advisors LLC New York, NY7.9MShares$64.9 Million2.22% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$48.8 Million7.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.54MShares$37.2 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$36.9 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $481M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...